Alberto Cukier

Learn More
BACKGROUND Formoterol is a fast-acting, long-acting beta-agonist. Its on-demand use by outpatients has been beneficial in controlling asthma. OBJECTIVE To evaluate the efficacy of formoterol as(More)
IgG4-related systemic sclerosing disease (IRSSD) is a new clinical entity that is characterized by elevated levels of serum IgG4; plasma cell infiltrates in tissues, including the pancreas, lung,(More)